vs
Jerash Holdings (US), Inc.（JRSH）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Jerash Holdings (US), Inc.的1.8倍（$75.5M vs $41.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 18.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-3.9M），过去两年Jerash Holdings (US), Inc.的营收复合增速更高（39.1% vs 31.3%）
Jerash Holdings (US), Inc. 是一家全球化服装制造商，为国际知名零售及服饰品牌生产高品质外套、运动服、休闲装及功能性服饰，核心市场覆盖北美、欧洲及亚太地区，在约旦及东南亚设有生产基地。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
JRSH vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$41.8M
营收增速更快
PBYI
高出9.7%
18.0%
自由现金流更多
PBYI
多$18.3M
$-3.9M
两年增速更快
JRSH
近两年复合增速
31.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.8M | $75.5M |
| 净利润 | $1.2M | — |
| 毛利率 | 16.9% | 69.3% |
| 营业利润率 | 4.7% | 22.7% |
| 净利率 | 2.8% | — |
| 营收同比 | 18.0% | 27.7% |
| 净利润同比 | 20261.5% | — |
| 每股收益（稀释后） | $0.09 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JRSHPBYI
| Q4 25 | $41.8M | $75.5M | ||
| Q3 25 | $42.0M | $54.5M | ||
| Q2 25 | $39.6M | $52.4M | ||
| Q1 25 | $29.3M | $46.0M | ||
| Q4 24 | $35.4M | $59.1M | ||
| Q3 24 | $40.2M | $80.5M | ||
| Q2 24 | $40.9M | $47.1M | ||
| Q1 24 | $21.6M | $43.8M |
净利润JRSHPBYI
| Q4 25 | $1.2M | — | ||
| Q3 25 | $461.6K | $8.8M | ||
| Q2 25 | $318.7K | $5.9M | ||
| Q1 25 | $-152.6K | $3.0M | ||
| Q4 24 | $-5.8K | — | ||
| Q3 24 | $655.3K | $20.3M | ||
| Q2 24 | $-1.3M | $-4.5M | ||
| Q1 24 | $-3.1M | $-4.8M |
毛利率JRSHPBYI
| Q4 25 | 16.9% | 69.3% | ||
| Q3 25 | 15.0% | 77.7% | ||
| Q2 25 | 15.4% | 76.5% | ||
| Q1 25 | 17.9% | 77.1% | ||
| Q4 24 | 15.2% | 76.4% | ||
| Q3 24 | 17.5% | 63.9% | ||
| Q2 24 | 11.3% | 77.4% | ||
| Q1 24 | 7.0% | 75.5% |
营业利润率JRSHPBYI
| Q4 25 | 4.7% | 22.7% | ||
| Q3 25 | 2.6% | 17.6% | ||
| Q2 25 | 2.4% | 12.7% | ||
| Q1 25 | 1.5% | 8.7% | ||
| Q4 24 | 2.0% | 22.6% | ||
| Q3 24 | 2.8% | 27.4% | ||
| Q2 24 | -2.0% | -4.6% | ||
| Q1 24 | -14.0% | -5.3% |
净利率JRSHPBYI
| Q4 25 | 2.8% | — | ||
| Q3 25 | 1.1% | 16.2% | ||
| Q2 25 | 0.8% | 11.2% | ||
| Q1 25 | -0.5% | 6.5% | ||
| Q4 24 | -0.0% | — | ||
| Q3 24 | 1.6% | 25.2% | ||
| Q2 24 | -3.3% | -9.6% | ||
| Q1 24 | -14.3% | -11.0% |
每股收益（稀释后）JRSHPBYI
| Q4 25 | $0.09 | $0.26 | ||
| Q3 25 | $0.04 | $0.17 | ||
| Q2 25 | $0.03 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $0.00 | $0.40 | ||
| Q3 24 | $0.05 | $0.41 | ||
| Q2 24 | $-0.11 | $-0.09 | ||
| Q1 24 | $-0.25 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $63.6M | $130.3M |
| 总资产 | $84.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资JRSHPBYI
| Q4 25 | $11.5M | $97.5M | ||
| Q3 25 | $12.0M | $94.4M | ||
| Q2 25 | $5.8M | $96.0M | ||
| Q1 25 | $13.3M | $93.2M | ||
| Q4 24 | $13.2M | $101.0M | ||
| Q3 24 | $16.3M | $96.7M | ||
| Q2 24 | $11.4M | $96.8M | ||
| Q1 24 | $12.4M | $107.2M |
总债务JRSHPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益JRSHPBYI
| Q4 25 | $63.6M | $130.3M | ||
| Q3 25 | $62.8M | $115.3M | ||
| Q2 25 | $62.7M | $104.7M | ||
| Q1 25 | $62.8M | $97.1M | ||
| Q4 24 | $63.1M | $92.1M | ||
| Q3 24 | $63.4M | $71.1M | ||
| Q2 24 | $62.9M | $48.5M | ||
| Q1 24 | $64.4M | $51.0M |
总资产JRSHPBYI
| Q4 25 | $84.2M | $216.3M | ||
| Q3 25 | $83.3M | $202.9M | ||
| Q2 25 | $81.7M | $194.9M | ||
| Q1 25 | $83.0M | $196.2M | ||
| Q4 24 | $79.8M | $213.3M | ||
| Q3 24 | $80.3M | $220.7M | ||
| Q2 24 | $76.7M | $205.0M | ||
| Q1 24 | $80.2M | $214.1M |
负债/权益比JRSHPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-3.9M | $14.4M |
| 自由现金流率自由现金流/营收 | -9.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | -3.25× | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流JRSHPBYI
| Q4 25 | $-3.8M | $14.4M | ||
| Q3 25 | $6.8M | $9.7M | ||
| Q2 25 | $-6.5M | $14.1M | ||
| Q1 25 | $1.9M | $3.6M | ||
| Q4 24 | $-3.0M | $15.6M | ||
| Q3 24 | $4.6M | $11.0M | ||
| Q2 24 | $-2.2M | $1.0M | ||
| Q1 24 | $-5.4M | $11.2M |
自由现金流JRSHPBYI
| Q4 25 | $-3.9M | $14.4M | ||
| Q3 25 | $6.4M | $9.7M | ||
| Q2 25 | $-6.9M | $14.1M | ||
| Q1 25 | $1.5M | $3.6M | ||
| Q4 24 | $-3.2M | $15.6M | ||
| Q3 24 | $4.4M | $11.0M | ||
| Q2 24 | $-2.3M | $1.0M | ||
| Q1 24 | $-5.8M | — |
自由现金流率JRSHPBYI
| Q4 25 | -9.3% | 19.1% | ||
| Q3 25 | 15.3% | 17.7% | ||
| Q2 25 | -17.5% | 26.8% | ||
| Q1 25 | 5.1% | 7.7% | ||
| Q4 24 | -8.9% | 26.4% | ||
| Q3 24 | 11.0% | 13.7% | ||
| Q2 24 | -5.7% | 2.1% | ||
| Q1 24 | -26.9% | — |
资本支出强度JRSHPBYI
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 1.2% | 0.0% | ||
| Q1 25 | 1.6% | 0.1% | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
现金转化率JRSHPBYI
| Q4 25 | -3.25× | — | ||
| Q3 25 | 14.72× | 1.10× | ||
| Q2 25 | -20.33× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.06× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
